These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38653109)

  • 1. Pharmacological inhibition of the Src homology phosphatase 2 confers partial protection in a mouse model of alcohol-associated liver disease.
    Hsu MF; Koike S; Chen CS; Najjar SM; Meng TC; Haj FG
    Biomed Pharmacother; 2024 Jun; 175():116590. PubMed ID: 38653109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic protein tyrosine phosphatase Shp2 disruption mitigates the adverse effects of ethanol in the liver by modulating oxidative stress and ERK signaling.
    Hsu MF; LeBleu G; Flores L; Parkhurst A; Nagy LE; Haj FG
    Life Sci; 2024 Mar; 340():122451. PubMed ID: 38253311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble Epoxide Hydrolase Hepatic Deficiency Ameliorates Alcohol-Associated Liver Disease.
    Mello A; Hsu MF; Koike S; Chu B; Cheng J; Yang J; Morisseau C; Torok NJ; Hammock BD; Haj FG
    Cell Mol Gastroenterol Hepatol; 2021; 11(3):815-830. PubMed ID: 33068774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic protein-tyrosine phosphatase 1B disruption and pharmacological inhibition attenuate ethanol-induced oxidative stress and ameliorate alcoholic liver disease in mice.
    Hsu MF; Koike S; Mello A; Nagy LE; Haj FG
    Redox Biol; 2020 Sep; 36():101658. PubMed ID: 32769011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of elafibranor on liver fibrosis and gut barrier function in a mouse model of alcohol-associated liver disease.
    Koizumi A; Kaji K; Nishimura N; Asada S; Matsuda T; Tanaka M; Yorioka N; Tsuji Y; Kitagawa K; Sato S; Namisaki T; Akahane T; Yoshiji H
    World J Gastroenterol; 2024 Jul; 30(28):3428-3446. PubMed ID: 39091710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-Asarone attenuates alcohol-induced hepatotoxicity in a murine model by ameliorating oxidative stress, inflammation, and modulating apoptotic-Autophagic cell death.
    Ali NAM; Abdelhamid AM; El-Sayed NM; Radwan A
    Toxicol Appl Pharmacol; 2024 Sep; 490():117041. PubMed ID: 39059505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyanidin-3-O-glucoside alleviates ethanol-induced liver injury by promoting mitophagy in a Gao-binge mouse model of alcohol-associated liver disease.
    He Q; Yin Z; Chen Y; Wu Y; Pan D; Cui Y; Zhang Z; Ma H; Li X; Shen C; Qin J; Wang S
    Biochim Biophys Acta Mol Basis Dis; 2024 Aug; 1870(6):167259. PubMed ID: 38796918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Fructose and Uric Acid Through Aldose Reductase Contribute to Experimental and Human Alcoholic Liver Disease.
    Wang M; Chen WY; Zhang J; Gobejishvili L; Barve SS; McClain CJ; Joshi-Barve S
    Hepatology; 2020 Nov; 72(5):1617-1637. PubMed ID: 32086945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
    Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
    Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases.
    Chen YN; LaMarche MJ; Chan HM; Fekkes P; Garcia-Fortanet J; Acker MG; Antonakos B; Chen CH; Chen Z; Cooke VG; Dobson JR; Deng Z; Fei F; Firestone B; Fodor M; Fridrich C; Gao H; Grunenfelder D; Hao HX; Jacob J; Ho S; Hsiao K; Kang ZB; Karki R; Kato M; Larrow J; La Bonte LR; Lenoir F; Liu G; Liu S; Majumdar D; Meyer MJ; Palermo M; Perez L; Pu M; Price E; Quinn C; Shakya S; Shultz MD; Slisz J; Venkatesan K; Wang P; Warmuth M; Williams S; Yang G; Yuan J; Zhang JH; Zhu P; Ramsey T; Keen NJ; Sellers WR; Stams T; Fortin PD
    Nature; 2016 Jul; 535(7610):148-52. PubMed ID: 27362227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual therapy with zinc acetate and rifaximin prevents from ethanol-induced liver fibrosis by maintaining intestinal barrier integrity.
    Fujimoto Y; Kaji K; Nishimura N; Enomoto M; Murata K; Takeda S; Takaya H; Kawaratani H; Moriya K; Namisaki T; Akahane T; Yoshiji H
    World J Gastroenterol; 2021 Dec; 27(48):8323-8342. PubMed ID: 35068872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The type of dietary fat modulates intestinal tight junction integrity, gut permeability, and hepatic toll-like receptor expression in a mouse model of alcoholic liver disease.
    Kirpich IA; Feng W; Wang Y; Liu Y; Barker DF; Barve SS; McClain CJ
    Alcohol Clin Exp Res; 2012 May; 36(5):835-46. PubMed ID: 22150547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combination of Pueraria lobata and Silybum marianum protects against alcoholic liver disease in mice.
    Feng R; Chen JH; Liu CH; Xia FB; Xiao Z; Zhang X; Wan JB
    Phytomedicine; 2019 May; 58():152824. PubMed ID: 30836218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nobiletin protects against alcohol-induced mitochondrial dysfunction and liver injury by regulating the hepatic NRF1-TFAM signaling pathway.
    Lu D; Huang A; Tong X; Zhang X; Li S; Yu X
    Redox Rep; 2024 Dec; 29(1):2395779. PubMed ID: 39221774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirtuin 6 ameliorates alcohol-induced liver injury by reducing endoplasmic reticulum stress in mice.
    Xin Y; Xu L; Zhang X; Yang C; Wang Q; Xiong X
    Biochem Biophys Res Commun; 2021 Mar; 544():44-51. PubMed ID: 33516881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epigenetic regulator SIRT6 protects the liver from alcohol-induced tissue injury by reducing oxidative stress in mice.
    Kim HG; Huang M; Xin Y; Zhang Y; Zhang X; Wang G; Liu S; Wan J; Ahmadi AR; Sun Z; Liangpunsakul S; Xiong X; Dong XC
    J Hepatol; 2019 Nov; 71(5):960-969. PubMed ID: 31295533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An integrated network pharmacology approach reveals that Ampelopsis grossedentata improves alcoholic liver disease via TLR4/NF-κB/MLKL pathway.
    Qiu P; Mi A; Hong C; Huang S; Ma Q; Luo Q; Qiu J; Jiang H; Chen Y; Chen F; Yan H; Zhao J; Kong Y; Du Y; Li C; Kong D; Efferth T; Lou D
    Phytomedicine; 2024 Sep; 132():155658. PubMed ID: 38981149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury.
    Wang Y; Liu Y; Sidhu A; Ma Z; McClain C; Feng W
    Am J Physiol Gastrointest Liver Physiol; 2012 Jul; 303(1):G32-41. PubMed ID: 22538402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linking Dysregulated AMPK Signaling and ER Stress in Ethanol-Induced Liver Injury in Hepatic Alcohol Dehydrogenase Deficient Deer Mice.
    Srinivasan MP; Bhopale KK; Amer SM; Wan J; Kaphalia L; Ansari GS; Kaphalia BS
    Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31581705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethanol metabolism and oxidative stress are required for unfolded protein response activation and steatosis in zebrafish with alcoholic liver disease.
    Tsedensodnom O; Vacaru AM; Howarth DL; Yin C; Sadler KC
    Dis Model Mech; 2013 Sep; 6(5):1213-26. PubMed ID: 23798569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.